MUMBAI, India, Oct. 19 -- Intellectual Property India has published a patent application (202617088973 A) filed by Apeiron Therapeutics Hong Kong Ltd. on July 21, 2026, for Pharmaceutical Composition Comprising Prmt5 Inhibitor And Egfr Inhibitor.
Inventors include Mao, Weifeng; Yao, Bing; Aswad, Fred Jullien; Li, Mingxi; Gu, Xiaohui; and Joseph, James David.
The application for the patent was published on October 16, 2026, under issue no. 42/2026.
Abstract: Disclosed is a pharmaceutical composition, comprising a protein arginine methyltransferase 5 (PRMT5) inhibitor and an epidermal growth factor receptor tyrosine kinase (EGFR) inhibitor. The pharmaceutical composition can be used to treat various cancers, including solid tumors. The com...